CIM: Who are your competitors?
GCCM: Currently licensed treatment centers and as of today there are 13 currently licensed.
CIM: What advantages will you have over your competitors?
GCCM: Our products are formulated and tested by world renowned experts in the field.
CIM:What disadvantages will you have with your competitors and how do you plan on resolving those disadvantages?
GCCM: The current license holders have a head start in the industry but we feel that can be overcome with our strategic go-to market plans.
CIM: What are your major hurdles and obstacles?
GCCM: The state of Florida office of medical marijuana use is currently extremely behind in meeting deadlines imposed by current legislation.
CIM: What previous experience does management have to assist Gulf Coast Canna Meds in executing on its business plan strategy?
GCCM: Bios are discussed in detail on our website.
CIM: How does the decision by Attorney Jeff Sessions to rescind the Cole Memorandum impact your business?
Q& A
106
Derwin Wallace: CIM Lori Daugherty, President: GCCM